ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.295
0.16%
US Dollar vs AUD
1.52903
-0.26%
Bitcoin
64,266.94
-0.35%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amylyx Pharmaceuticals Inc (AMLX)

  7. Amylyx Pharmaceuticals Inc (AMLX) News

AMLX Amylyx Pharmaceuticals Inc

1.78
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Amylyx Pharmaceuticals Inc AMLX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 1.78 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.78
more quote information »

Recent News

Date Time Source Heading
10/4/202423:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/4/202419:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/4/202423:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/4/202420:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/4/202422:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/4/202420:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/3/202420:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/3/202420:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/3/202423:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/3/202420:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/3/202420:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
15/3/202400:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/3/202420:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/3/202423:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/3/202420:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/3/202423:10EDGAR2Form 8-K - Current report
08/3/202423:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
08/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202421:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
29/2/202410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202410:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202410:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202421:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
24/2/202408:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
23/2/202408:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/2/202400:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202423:08EDGAR2Form 8-K - Current report
22/2/202423:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202421:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
16/2/202408:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
16/2/202401:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/2/202421:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
09/2/202401:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
12/1/202409:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202308:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202301:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
20/12/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202323:00EDGAR2Form 8-K - Current report
05/12/202301:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
30/11/202309:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202323:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
28/11/202301:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
22/11/202301:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
21/11/202312:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202323:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:00BWAmylyx Pharmaceuticals Reports Third Quarter 2023 Financial..

Your Recent History

NASDAQ
AMLX
Amylyx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved